Search research articles
Contact Us
Filters
Showing results (151-160 of 177) with videos related to
Page
of 18
Sort By:
British Journal of Cancer
|
November 1, 1990
Prognostic factors for survival in soft tissue sarcoma
J N el-Jabbour, S S Akhtar, G R Kerr, et al.
British Journal of Cancer
|
August 1, 1995
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours
H Gabra, L Taylor, B B Cohen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity
M E O'Brien, D M Eccles, S G Allen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1996
Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing mice
J Cummings, S P Langdon, A A Ritchie, et al.
Cancer Research
|
March 1, 1996
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis
H Gabra, J E Watson, K J Taylor, et al.
British Journal of Cancer
|
January 1, 1997
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy
D A Cameron, E D Anderson, P Levack, et al.
British Journal of Cancer
|
September 1, 1992
An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer
L G Bobrow, F R Hirsch, F G Hay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 1998
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts
S P Langdon, A A Ritchie, M Muir, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma
R C Leonard, G E Smart, J R Livingstone, et al.
Cancer Research
|
November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
S P Langdon, M M Hawkes, F G Hay, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 177) with videos related to
Sort By:
Page
of 18
British Journal of Cancer
|
November 1, 1990
Prognostic factors for survival in soft tissue sarcoma
J N el-Jabbour, S S Akhtar, G R Kerr, et al.
British Journal of Cancer
|
August 1, 1995
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours
H Gabra, L Taylor, B B Cohen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity
M E O'Brien, D M Eccles, S G Allen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1996
Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing mice
J Cummings, S P Langdon, A A Ritchie, et al.
Cancer Research
|
March 1, 1996
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis
H Gabra, J E Watson, K J Taylor, et al.
British Journal of Cancer
|
January 1, 1997
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy
D A Cameron, E D Anderson, P Levack, et al.
British Journal of Cancer
|
September 1, 1992
An immunohistochemical investigation of diagnostic biopsy material taken from short and long term survivors with small cell lung cancer
L G Bobrow, F R Hirsch, F G Hay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 1998
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts
S P Langdon, A A Ritchie, M Muir, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma
R C Leonard, G E Smart, J R Livingstone, et al.
Cancer Research
|
November 1, 1988
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines
S P Langdon, M M Hawkes, F G Hay, et al.
Page
of 18